National and Kapodistrian University of Athens
Διερεύνηση της δράσης των αντιμικροβιακών πεπτιδίων defensins ( alpha και beta) έναντι διαφόρων παθογόνων μικροοργανισμών
Abstract
dc:descriptionEndogenous cationic antimicrobial peptides mediate innate immunity inevery species in which they have been investigated. Cathelicidins anddefensins are the two major families of antimicrobial peptides in mammals.They are abundant components of phagocytic leukocytes and are released byepithelial cells at mucosal surfaces. In the small intestine, Paneth cells at thebase of the crypts of Lieberkühn secrete α-defensins at high levels inresponse to cholinergic stimulation and when exposed to bacterial antigens.The release of Paneth cell products into the crypt lumen is inferred toprotect mitotically active crypt cells from colonization by potentialpathogens and confers protection from enteric infection. In addition, α-Defensins in Paneth cell secretions may interact with bacteria in theintestinal lumen above the crypt–villus boundary and influence thecomposition of the enteric microbial flora. Human b-defensins were alsodiscovered and characterized during the last decade. In particular, variousaspects of their gene location, expression patterns and the transcriptionfactors involved in their regulation in vivo have been extensively studied.Structural studies of β-defensins provide the molecular basis for a betterunderstanding of their properties, functions and their potential for practicalapplications. The antimicrobial activity of b-defensins, is clearly not theonly function of these peptides. Additional roles of human defensins includethe ability to act as chemokines as well as induce chemokine productionleading to recruitment of leukocytes to the site of infection, the promotionof wound healing and an ability tomodulate adaptive immunity. It appearsthat many of these properties are mediated though direct interaction ofpeptides with the cells of the innate immune response including monocytes,dendritic cells, T cells and epithelial cells. Although studies of theimmunomodulatory properties of these peptides are in their infancy, there isa growing body of evidence suggesting that the immunomodulatoryproperties of these small, naturally occurring molecules might be harnessedfor development as novel therapeutic agents. In our study we focused on157human β-defensin 2 (hBD-2), a 41-amino acid β-defensin. We determinedthe microbicidal activity of synthetic hBD-2 against nosocomial pathogensbelonging to 8 different bacterial and yeast species and exhibiting variousantimicrobial resistance phenotypes. The native disulfide connectivity wasfound essential for the bactericidal activity of hBD-2, while sodium chlorideconcentration was reversely associated with its potency. hBD-2 exhibitedhigh bactericidal activity against Acinetobacter baumannii, Pseudomonasaeruginosa, Enterococcus faecalis, Enterococcus faecium andStaphylococcus aureus clinical strains. Characteristically, A. baumanniistrains that exhibited multidrug-resistant phenotypes were susceptible tolowest concentrations of hBD-2 as compared with sensitive to antibiotics A.baumannii strains. Bactericidal activity of hBD-2 was less pronouncedagainst Escherichia coli, Klebsiella pneumoniae and Proteus mirabils strainsbut was significantly enhanced against strains of these species that exhibitedresistance to several β-lactam antibiotics. These observations giveindications that the natural hBD-2 has a potential therapeutic role againstbacterial pathogens and particularly against those exhibiting multidrugresistantphenotypes.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karagounis, Panagiotis
- Καραγκούνης, Παναγιώτης
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29781